ReviewJournal of personalized medicine2022

The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy.

Danai-Thomais Kostourou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.